vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and USA Compression Partners, LP (USAC). Click either name above to swap in a different company.

USA Compression Partners, LP is the larger business by last-quarter revenue ($252.5M vs $202.1M, roughly 1.2× CORCEPT THERAPEUTICS INC). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs 11.0%, a 1.0% gap on every dollar of revenue. On growth, CORCEPT THERAPEUTICS INC posted the faster year-over-year revenue change (11.1% vs 2.7%). USA Compression Partners, LP produced more free cash flow last quarter ($87.7M vs $38.4M). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs 4.9%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

CORT vs USAC — Head-to-Head

Bigger by revenue
USAC
USAC
1.2× larger
USAC
$252.5M
$202.1M
CORT
Growing faster (revenue YoY)
CORT
CORT
+8.4% gap
CORT
11.1%
2.7%
USAC
Higher net margin
CORT
CORT
1.0% more per $
CORT
12.0%
11.0%
USAC
More free cash flow
USAC
USAC
$49.3M more FCF
USAC
$87.7M
$38.4M
CORT
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
4.9%
USAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORT
CORT
USAC
USAC
Revenue
$202.1M
$252.5M
Net Profit
$24.3M
$27.8M
Gross Margin
98.7%
Operating Margin
2.2%
30.3%
Net Margin
12.0%
11.0%
Revenue YoY
11.1%
2.7%
Net Profit YoY
-21.0%
9.1%
EPS (diluted)
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
USAC
USAC
Q4 25
$202.1M
$252.5M
Q3 25
$207.6M
$250.3M
Q2 25
$194.4M
$250.1M
Q1 25
$157.2M
$245.2M
Q4 24
$181.9M
$245.9M
Q3 24
$182.5M
$240.0M
Q2 24
$163.8M
$235.3M
Q1 24
$146.8M
$229.3M
Net Profit
CORT
CORT
USAC
USAC
Q4 25
$24.3M
$27.8M
Q3 25
$19.7M
$34.5M
Q2 25
$35.1M
$28.6M
Q1 25
$20.5M
$20.5M
Q4 24
$30.7M
$25.4M
Q3 24
$47.2M
$19.3M
Q2 24
$35.5M
$31.2M
Q1 24
$27.8M
$23.6M
Gross Margin
CORT
CORT
USAC
USAC
Q4 25
98.7%
Q3 25
97.8%
Q2 25
98.2%
Q1 25
98.5%
Q4 24
98.4%
Q3 24
98.4%
Q2 24
98.5%
Q1 24
98.3%
Operating Margin
CORT
CORT
USAC
USAC
Q4 25
2.2%
30.3%
Q3 25
4.9%
33.5%
Q2 25
13.7%
30.6%
Q1 25
2.2%
28.3%
Q4 24
13.9%
30.3%
Q3 24
25.5%
31.5%
Q2 24
21.7%
32.9%
Q1 24
20.1%
29.2%
Net Margin
CORT
CORT
USAC
USAC
Q4 25
12.0%
11.0%
Q3 25
9.5%
13.8%
Q2 25
18.1%
11.4%
Q1 25
13.1%
8.4%
Q4 24
16.9%
10.3%
Q3 24
25.9%
8.1%
Q2 24
21.7%
13.3%
Q1 24
18.9%
10.3%
EPS (diluted)
CORT
CORT
USAC
USAC
Q4 25
$0.20
Q3 25
$0.16
Q2 25
$0.29
Q1 25
$0.17
Q4 24
$0.25
Q3 24
$0.41
Q2 24
$0.32
Q1 24
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
USAC
USAC
Cash + ST InvestmentsLiquidity on hand
$372.2M
$8.6M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$647.8M
Total Assets
$836.7M
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
USAC
USAC
Q4 25
$372.2M
$8.6M
Q3 25
$421.7M
Q2 25
$342.2M
$2.0K
Q1 25
$322.8M
$2.0K
Q4 24
$383.3M
$14.0K
Q3 24
$380.3M
$79.0K
Q2 24
$473.2M
$9.0K
Q1 24
$410.8M
$8.0K
Total Debt
CORT
CORT
USAC
USAC
Q4 25
$2.5B
Q3 25
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
CORT
CORT
USAC
USAC
Q4 25
$647.8M
Q3 25
$631.9M
Q2 25
$635.8M
Q1 25
$683.3M
Q4 24
$679.6M
Q3 24
$638.8M
Q2 24
$596.2M
Q1 24
$547.9M
Total Assets
CORT
CORT
USAC
USAC
Q4 25
$836.7M
$2.6B
Q3 25
$823.6M
$2.7B
Q2 25
$801.7M
$2.7B
Q1 25
$846.5M
$2.7B
Q4 24
$840.6M
$2.7B
Q3 24
$784.3M
$2.8B
Q2 24
$714.6M
$2.8B
Q1 24
$655.9M
$2.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
USAC
USAC
Operating Cash FlowLast quarter
$38.4M
$139.5M
Free Cash FlowOCF − Capex
$38.4M
$87.7M
FCF MarginFCF / Revenue
19.0%
34.8%
Capex IntensityCapex / Revenue
0.0%
20.5%
Cash ConversionOCF / Net Profit
1.58×
5.02×
TTM Free Cash FlowTrailing 4 quarters
$277.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
USAC
USAC
Q4 25
$38.4M
$139.5M
Q3 25
$54.5M
$75.9M
Q2 25
$43.9M
$124.2M
Q1 25
$5.1M
$54.7M
Q4 24
$59.3M
$130.2M
Q3 24
$73.8M
$48.5M
Q2 24
$41.2M
$96.7M
Q1 24
$23.8M
$65.9M
Free Cash Flow
CORT
CORT
USAC
USAC
Q4 25
$38.4M
$87.7M
Q3 25
$51.9M
Q2 25
$43.9M
$101.1M
Q1 25
$5.0M
$36.3M
Q4 24
$59.2M
$101.2M
Q3 24
$72.2M
$19.8M
Q2 24
$40.8M
$48.2M
Q1 24
$-32.7M
FCF Margin
CORT
CORT
USAC
USAC
Q4 25
19.0%
34.8%
Q3 25
20.7%
Q2 25
22.6%
40.4%
Q1 25
3.2%
14.8%
Q4 24
32.5%
41.1%
Q3 24
39.5%
8.2%
Q2 24
24.9%
20.5%
Q1 24
-14.3%
Capex Intensity
CORT
CORT
USAC
USAC
Q4 25
0.0%
20.5%
Q3 25
0.0%
9.6%
Q2 25
0.0%
9.3%
Q1 25
0.1%
7.5%
Q4 24
0.1%
11.8%
Q3 24
0.9%
12.0%
Q2 24
0.3%
20.6%
Q1 24
0.0%
43.0%
Cash Conversion
CORT
CORT
USAC
USAC
Q4 25
1.58×
5.02×
Q3 25
2.77×
2.20×
Q2 25
1.25×
4.35×
Q1 25
0.25×
2.66×
Q4 24
1.93×
5.12×
Q3 24
1.56×
2.51×
Q2 24
1.16×
3.10×
Q1 24
0.86×
2.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

Related Comparisons